Ectopic adrenocorticotropin syndrome with prostatic carcinoma.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000230:Adenocarcinoma / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D001786:Blood Glucose / Q000032:analysis; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use; D008875:Middle Aged; D008939:Mitotane / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009384:Paraneoplastic Endocrine Syndromes / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D011188:Potassium / Q000097:blood; D011471:Prostatic Neoplasms / Q000150:complications*; D011618:Psychotic Disorders / Q000209:etiology; D013148:Spironolactone / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D001786:Blood Glucose; D013148:Spironolactone; D008939:Mitotane; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011188:Potassium; D008797:Metyrapone